← Back to Newly Diagnosed
Carnergia · Newly Diagnosed

What Happens Now?

The short version

Your baby starts a daily carnitine supplement right away, usually a liquid given by syringe or mixed into a small amount of milk. A metabolic specialist leads the care, with your pediatrician as the everyday contact. The first few months are the steepest part of the learning curve, and children treated from birth do very well.

A diagnosis brings a lot of new information at once. This page is a map of the first weeks and months, so nothing catches you off guard. It is not your care team's plan. It is the shape of what that plan usually looks like.

How do you build your child's care team?

Your child's care team is usually two people to start: your pediatrician and a metabolic specialist. Your pediatrician is your everyday contact and coordinates the rest. The metabolic specialist (a metabolic geneticist, or sometimes a genetics doctor) knows PCD best. They set the dose, read the labs, and adjust things as your child grows. Some families also work with a metabolic dietitian, who helps with feeding questions. That is helpful but not required.

If there is no metabolic specialist near you, ask your pediatrician about telehealth. This is a small specialty, and many families see their specialist by video most of the time. And please do not save every question for the specialist. While you wait for that first appointment, your pediatrician is a very good person to ask.

How does treatment start?

Treatment starts as soon as the diagnosis is confirmed, with a daily carnitine supplement called levocarnitine that your child will take for life. For a baby it is usually a liquid. You can give it straight from a syringe or mix it into a small amount of breast milk or formula. As your child gets older there are other forms, and your family can find what works best. Your metabolic team calculates the dose from your child's weight and raises it as they grow.

The single most important thing you can do is give the dose on schedule. Levocarnitine is taken more than once a day, and regular doses are what keep carnitine levels steady. Building a routine now, while your baby's day is still simple, is the best gift you can give your future self.

What do the first few months look like?

The first few months are the most disorienting, not because they are the most medically complicated, but because you are learning a whole new routine while also caring for a newborn. That is a lot. Almost every family says the same thing: the curve is steepest at the start, and what feels urgent and strange right now becomes ordinary.

Here is what to expect. Frequent blood tests at first, sometimes every few weeks, until the levels are steady and the dose is right. Dose increases as your baby gains weight. A medication routine you tie to something you already do every day, like the morning bottle, so it becomes part of the day instead of one more task. And one thing to set up early: know your specialist's name, how to reach their on-call line after hours, and which symptoms mean call now instead of waiting for the next appointment.

What is the long-term outlook for PCD?

For children who are diagnosed early and take their carnitine every day, the outlook is very good, and most live normal lives. Nearly every parent asks me some version of "Will my child be okay?" It is the right question. Children found by newborn screening and treated from infancy have a big advantage over those diagnosed later, because the body gets the carnitine it needs before low levels have a chance to cause harm. That is your child.

I'm a person living with PCD, not your doctor. Everything here is to help you understand and ask good questions; your child's metabolic team makes the medical decisions.

Last updated October 2026.

Where this comes from

I wrote this page from the studies below and from living with PCD. Your care team is the final word on your child.

  • Magoulas PL, El-Hattab AW. "Systemic primary carnitine deficiency: an overview of clinical manifestations, diagnosis, and management." Orphanet Journal of Rare Diseases, 2012. https://doi.org/10.1186/1750-1172-7-68
  • Pınar E, Zubarioglu T, Babazade H, et al. "Primary systemic carnitine deficiency: Phenotypic variability, diagnostic challenges, and long-term outcomes." Pediatrics International, 2025. https://doi.org/10.1111/ped.70211